-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vertex Pharmaceuticals Inc / Ma quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Vertex Pharmaceuticals Inc / Ma Operating Income (Loss) for the quarter ending September 30, 2024 was $1.12B, a 7.53% increase year-over-year.
- Vertex Pharmaceuticals Inc / Ma Operating Income (Loss) for the twelve months ending September 30, 2024 was -$270M, a 107% decline year-over-year.
- Vertex Pharmaceuticals Inc / Ma annual Operating Income (Loss) for 2023 was $3.83B, a 11% decline from 2022.
- Vertex Pharmaceuticals Inc / Ma annual Operating Income (Loss) for 2022 was $4.31B, a 54.8% increase from 2021.
- Vertex Pharmaceuticals Inc / Ma annual Operating Income (Loss) for 2021 was $2.78B, a 2.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)